Axa
USNA icon

Axa’s Usana Health Sciences USNA Stock Holding History

Axa’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,061
Closed -$919K – 1179
2025
Q1 		$919K Buy
+34,061
New +$1.08M ﹤0.01% 857
2016
Q1 		– Sell
-15,400
Closed -$984K – 1420
2015
Q4 		$984K Sell
15,400
-25,000
-62% -$1.62M ﹤0.01% 914
2015
Q3 		$2.71M Sell
40,400
-800
-2% -$56.6K 0.01% 716
2015
Q2 		$2.81M Buy
41,200
+2,200
+6% +$140K 0.01% 719
2015
Q1 		$2.17M Buy
39,000
+4,400
+13% +$226K 0.01% 789
2014
Q4 		$1.77M Buy
34,600
+5,400
+18% +$265K 0.01% 827
2014
Q3 		$1.08M Buy
29,200
+4,000
+16% +$144K ﹤0.01% 888
2014
Q2 		$985K Sell
25,200
-10,000
-28% -$371K ﹤0.01% 928
2014
Q1 		$1.33M Buy
35,200
+23,400
+198% +$817K 0.01% 870
2013
Q4 		$446K Buy
11,800
+3,000
+34% +$115K ﹤0.01% 1088
2013
Q3 		$382K Buy
+8,800
New +$353K ﹤0.01% 1054

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Axa's USNA Position: Q2 2025 in Review

Axa sold out of Usana Health Sciences (USNA) in Q2 2025, closing a stake of 34,061 shares — an estimated $919K sold.

Axa first reported a position in USNA in Q3 2013 and held it in 11 quarters. The position peaked at $2.81M in Q2 2015. 164 funds tracked by Wall St. Rank hold USNA as of Q2 2025.

  • Axa reported no remaining Usana Health Sciences position as of Q2 2025 after selling out during the quarter.
  • Axa sold 34,061 Usana Health Sciences shares in Q2 2025, an estimated $919K.
  • Axa first reported a position in Usana Health Sciences in Q3 2013 and held it in 11 quarters.
  • Axa's Usana Health Sciences position peaked at $2.81M in Q2 2015.
  • 164 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2025.

Based on Axa's 13F filing for Q2 2025, filed 14 Aug 2025.